Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 721 AL 735

Sleep disturbances in Parkinson disease and their potential role in heterogeneity

Gunn DG, Naismith SL, Lewis SJ.

J Geriatr Psychiatry Neurol. 2010 Jun;23(2):131-7. doi: 10.1177/0891988709358591. Epub 2010 Jan 25.

Treatment strategies for Parkinson's disease

Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM, Ma HJ, Jiao SJ, Liu P.

Neurosci Bull. 2010 Feb;26(1):66-76. doi: 10.1007/s12264-010-0302-z.

Neuropathology of Alzheimer's disease

Perl DP.

Mt Sinai J Med. 2010 Jan-Feb;77(1):32-42. doi: 10.1002/msj.20157.

Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application

Constantinescu G, Theodoros D, Russell T, Ward E, Wilson S, Wootton R.

Int J Lang Commun Disord. 2010 Nov-Dec;45(6):630-44. doi: 10.3109/13682820903470569.

Safety and efficacy of nilotinib in chronic phase chronic myeloid leukemia in a patient with Wolf-Parkinson-White disease and hematological resistance after suboptimal response to imatinib at six months

Cannella L, Breccia M, Loglisci G, Federico V, Santopietro M, Alimena G.

Acta Oncol. 2010 Apr;49(3):399-400. doi: 10.3109/02841860903521129.

No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease

Collins SJ, Schuur M, Boyd A, Lewis V, Klug GM, McGlade A, van Oosterhout A, Breedveld G, Oostra BA, Masters C, Van Duijn CM.

Neurosci Lett. 2010 Mar 12;472(1):16-8. doi: 10.1016/j.neulet.2010.01.043. Epub 2010 Jan 25.

Recent advances in PET imaging for evaluation of Parkinson's disease

Sioka C, Fotopoulos A, Kyritsis AP.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1594-603. doi: 10.1007/s00259-009-1357-9. Epub 2010 Jan 27.

C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease

Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA.

Dev Dyn. 2010 May;239(5):1282-95. doi: 10.1002/dvdy.22231.

Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's disease

Schneider CB, Pilhatsch M, Rifati M, Jost WH, Wodarz F, Ebersbach G, Djundja D, Fuchs G, Gies A, Odin P, Reifschneider G, Wolz M, Bottesi A, Bauer M, Reichmann H, Storch A.

Mov Disord. 2010 Apr 30;25(6):777-83. doi: 10.1002/mds.22985.

[Melanomas and basal cell carcinomas in a patient with Parkinson disease]

Hiraldo A, Gómez-Moyano E, Martínez S, Sanz A.

Actas Dermosifiliogr. 2010 Jan-Feb;101(1):95-6.

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease

Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC.

PLoS One. 2010 Jan 25;5(1):e8856. doi: 10.1371/journal.pone.0008856.

Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis

Białecka M, Kurzawski M, Tan EK, Drozdzik M.

Neurosci Lett. 2010 Mar 12;472(1):53-5. doi: 10.1016/j.neulet.2010.01.055. Epub 2010 Feb 1.

Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research

Pavon JM, Whitson HE, Okun MS.

Maturitas. 2010 Apr;65(4):352-8. doi: 10.1016/j.maturitas.2010.01.001. Epub 2010 Feb 1.

Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure

Bothe MR, Uttner I, Otto M.

J Neural Transm (Vienna). 2010 Mar;117(3):353-67. doi: 10.1007/s00702-010-0370-2. Epub 2010 Jan 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias